Lopid and Pregnancy

The FDA considers Lopid a pregnancy Category C medicine, meaning that while it showed potential harm to unborn babies in previous animal studies, it has never been tested in pregnant women. However, a pregnant woman may still take Lopid if her healthcare provider decides that its benefits outweigh the possible risks to her unborn child. If you are taking Lopid and pregnancy has occurred (or you are planning on becoming pregnant in the near future), be sure to let your healthcare provider know.

Lopid Information

Is Lopid Safe During Pregnancy? -- An Overview

Lopid^® (gemfibrozil) is considered a pregnancy Category C medicine by the U.S. Food and Drug Administration (FDA), which means that Lopid has not been studied in pregnant women. However, when studied in pregnant animals, Lopid was found to potentially cause harm to an unborn baby.

It is important to note that animals do not always respond to medicines the same way that humans do.

Lopid and Pregnancy Category C

The U.

S. Food and Drug Administration (FDA) uses a pregnancy category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that show side effects to the fetus in animal studies, but for which no human studies in pregnant women have been done. A pregnancy Category C medicine may still be given to a pregnant woman if her healthcare provider believes that its benefits to the pregnant woman outweigh the possible risks to the unborn child.

If you are pregnant or thinking of becoming pregnant while taking Lopid, let your healthcare provider know. Your healthcare provider will consider both the benefits and risks of Lopid during pregnancy before making a recommendation for your particular situation.